Utility of Preoperative Computed Tomography–Based Body Metrics in Relation to Postoperative Complications in Pediatric Liver Transplantation Recipients

Martijn V. Verhagen, Stef Levolger, Jan Binne Hulshoff, Maureen J. M. Werner, Hubert P. J. Doef, Alain R. Viddeleer, Ruben H. Kleine, Robbert J. Haas – 11 June 2021 – Computed tomography (CT)‐derived body metrics such as skeletal muscle index (SMI), psoas muscle index (PMI), and subcutaneous fat area index (ScFI) are measurable components of sarcopenia, frailty, and nutrition. While these body metrics are advocated in adults for predicting postoperative outcomes after liver transplantation (LT), little is known about their value in pediatric populations.

Medicaid Expansion Association With End‐Stage Liver Disease Mortality Depends on Leniency of Medicaid Hepatitis C Virus Coverage

Nabeel A. Wahid, Jihui Lee, Alyson Kaplan, Brett E. Fortune, Monika M. Safford, Robert S. Brown, Russell Rosenblatt – 11 June 2021 – The Affordable Care Act expanded Medicaid around the same time that direct‐acting antivirals became widely available for the treatment of hepatitis C virus (HCV). However, there is significant variation in Medicaid HCV treatment eligibility criteria between states. We explored the combined effects of Medicaid expansion and leniency of HCV coverage under Medicaid on liver outcomes.

Subscribe to